NYMC Faculty Publications

Implications of the New National Guidelines for Hypertension

DOI

10.1097/CRD.0000000000000187

Journal Title

Cardiology in Review

First Page

55

Last Page

61

Document Type

Article

Publication Date

January 2018

Department

Medicine

Abstract

Automated validated devices should be used for measuring blood pressure (BP). A systolic BP between 120 and 129 mm Hg with a diastolic BP /=130 mm Hg or an average diastolic BP >/= 80 mm Hg. Lifestyle measures plus BP lowering drugs should be used for primary prevention of CVD in persons with an estimated 10-year risk of atherosclerotic CVD >/= 10% and an average systolic BP >/=130 mm Hg or an average diastolic BP >/= 80 mm Hg. Lifestyle measures plus BP lowering drugs should be used for primary prevention of CVD in persons with an estimated 10-year risk of atherosclerotic CVD of /= 140 mm Hg or an average diastolic BP >/= 90 mm Hg. Initiate antihypertensive drug therapy with 2 first-line drugs from different classes either as separate agents or in a fixed-dose combination in persons with a BP >/= 140/90 mm Hg or with a BP >20/10 mm Hg above their BP target. White coat hypertension must be excluded before initiating treatment with antihypertensive drugs in persons with hypertension at low risk for atherosclerotic CVD. Antihypertensive drug treatment for different disorders is discussed.

Link to Full Text

Share

COinS